Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 29 articles PubMed · modèle : gemma4:31b
Résumé
Epimedium, commonly known as Horny Goat Weed, is a genus of medicinal plants used traditionally as a tonic and aphrodisiac [PMID:35998248, PMID:21215308]. Modern research indicates it possesses broad pharmacological activities, including osteoprotective, neuroprotective, and anti-inflammatory effects [PMID:38801026, PMID:27445824].
Contexte
Epimedium (family Berberidaceae) is a genus comprising approximately 52 to 62 species, with many distributed in China [PMID:21215308, PMID:36120133]. It is known by various names, including Yin Yang Huo, Barrenwort, and Horny Goat Weed [PMID:21215308, PMID:27445824].
Usages traditionnels
Traditionally used in Asian countries as a tonic, aphrodisiac, and anti-rheumatic agent [PMID:35998248, PMID:27445824]. In Traditional Chinese Medicine (TCM), it is used to tonify kidney and yang, strengthen tendons and bones, and treat impotence and spermatorrhea [PMID:38801026, PMID:40185257].
Composés actifs
The primary active components are prenyl-flavonoids, specifically icariin, icaritin, and icariside II [PMID:21215308, PMID:39066475, PMID:27445824]. Other identified constituents include epimedin A, B, and C, baohuoside I, isopentenyl flavonols, neolignans, and water-soluble polysaccharides composed of mannose, rhamnose, galacturonic acid, glucose, and galactose [PMID:37108810, PMID:37894651, PMID:28278623, PMID:36746589].
Mécanisme d'action
Icariin promotes osteogenic differentiation by upregulating alpha-enolase (Eno1) and mediating the BMP/Smad4 signaling pathway [PMID:37125075]. It modulates bone remodeling by activating Wnt/β-catenin and PI3K/Akt signaling to promote osteoblasts, while suppressing RANKL-mediated NF-κB activation to inhibit osteoclasts [PMID:42193945]. Additionally, Epimedium-derived exosome-like nanovesicles may reshape gut microbiota and suppress the TLR4/NF-κB pathway to reduce systemic inflammation [PMID:41432450].
Preuves cliniques
Preuve AOsteoporosis
Epimedium has been evaluated as an adjunctive or alternative to conventional pharmacotherapy to improve bone mineral density (BMD) and effective rate [PMID:35431937].
Preuve CSexual Dysfunction
Used traditionally for impotence and sexual dysfunction, with modern pharmacology demonstrating efficacy in strengthening yang [PMID:21215308, PMID:38801026].
Preuve CNeurodegenerative Diseases
Icariin exhibits potential preventive and therapeutic effects in models of Alzheimer's disease by inhibiting amyloid β (1-42) production and BACE-1 expression [PMID:30342950].
Sécurité et effets indésirables
Oral forms of horny goat weed have not been linked to serum aminotransferase elevations or clinically apparent liver injury [PMID:35998248].
Synthèse des preuves
The evidence consists primarily of review articles and preclinical in vitro/in vivo studies (Level C and D), with one systematic review and meta-analysis (Level A) focusing on osteoporosis.
Sources PubMed
1.PMID: 35998248 (2012) — Botanicals and Their Bioactive Phytochemicals for Women's Health. · Pharmacological reviews
2.PMID: 32089233 (2020) — Pharmacological effects of icariin. · Advances in pharmacology (San Diego, Calif.)
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
· Phytomedicine : international journal of phytotherapy and phytopharmacology
6.PMID: 26268839 (2016) — An Evidence-Based Systematic Review of Yin Yang Huo (Epimedium spp.) by the Natural Standard Research Collaboration. · Journal of dietary supplements
7.PMID: 40873547 (2025) — Progress in the application of epimedium and its major bioactive components in the treatment of orthopedic diseases. · Frontiers in pharmacology
8.PMID: 39066475 (2024) — Cancer-Related Therapeutic Potential of Epimedium and Its Extracts. · Nutrition and cancer
9.PMID: 37108810 (2023) — The Effect of Epimedium Isopentenyl Flavonoids on the Broiler Gut Health Using Microbiomic and Metabolomic Analyses. · International journal of molecular sciences
10.PMID: 36120133 (2022) — Taxonomy of Epimedium (Berberidaceae) with special reference to Chinese species. · Chinese herbal medicines
11.PMID: 27445824 (2016) — Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its Derivatives. · Frontiers in pharmacology
12.PMID: 29075193 (2017) — Icariin, an Anti-atherosclerotic Drug from Chinese Medicinal Herb Horny Goat Weed. · Frontiers in pharmacology
13.PMID: 30342950 (2019) — An outline for the pharmacological effect of icariin in the nervous system. · European journal of pharmacology
14.PMID: 37894651 (2023) — Advancements in the Biotransformation and Biosynthesis of the Primary Active Flavonoids Derived from Epimedium. · Molecules (Basel, Switzerland)
15.PMID: 36746589 (2023) — Research progress on the extraction technology and activity study of Epimedium polysaccharides. · Carbohydrate polymers
16.PMID: 37525296 (2023) — Effects of genus Epimedium in the treatment of osteoarthritis and relevant signaling pathways. · Chinese medicine
17.PMID: 37029621 (2024) — A new flavonoid from Epimedium brevicornu Maxim. · Natural product research
18.PMID: 35431937 (2022) — Epimedium for Osteoporosis Based on Western and Eastern Medicine: An Updated Systematic Review and Meta-Analysis. · Frontiers in pharmacology
19.PMID: 37125075 (2023) — Icariin promotes osteogenic differentiation by upregulating alpha-enolase expression. · Biochemistry and biophysics reports
20.PMID: 40185257 (2025) — Epimedium and its chemical constituents in cancer treatment: A comprehensive review of traditional applications, antitumor effects, pharmacokinetics, delivery systems, and toxicology. · Journal of ethnopharmacology
21.PMID: 38801026 (2024) — Epimedium Linn: A Comprehensive Review of Phytochemistry, Pharmacology, Clinical Applications and Quality Control. · Chemistry & biodiversity
22.PMID: 38027566 (2023) — A literature review on Epimedium, a medicinal plant with promising slow aging properties. · Heliyon
23.PMID: 41432450 (2026) — Epimedium-Derived Exosome-like Nanovesicles Regulate Lipid Metabolism via the "Gut-Kidney Axis" for Multitargeted Inhibition of Sepsis-Associated Acute Kidney Injury. · ACS applied materials & interfaces
24.PMID: 22041065 (2011) — Flavonol glycosides from Epimedium pubescens. · Chemical & pharmaceutical bulletin
25.PMID: 8862041 (1996) — Flavonoids from Epimedium wanshanense. · Phytochemistry
26.PMID: 28278623 (2017) — Anti-inflammatory neolignans from Epimedium pseudowushanese. · Natural product research
27.PMID: 42193945 (2026) — Plant-Derived Bioactive Ingredients for Osteoporosis and Bone Regeneration: Mechanisms, Pharmacology, and Delivery Strategies. · Cells